Veregen

Treatment for Condylomata Acuminata

MediGene Announces FDA Acceptance of New Drug Application for Polyphenon E Ointment for the Treatment of Genital Warts

The active substance in Polyphenon E Ointment is a green tea extract with a defined catechin composition. MediGene is developing this drug for the treatment of various skin tumors.

Genital Warts

Genital warts are one of the most common and fastest spreading venereal diseases worldwide. Genital warts are benign, but disfiguring and contagious skin tumors in the genital and anal area, which are difficult to treat. Approximately 14 million people in North America and 15 million people in Europe are infected by human papilloma viruses (HPV type 6 or 11), which cause genital warts.

Source: MediGene AG

Posted: December 2005

Related Articles

Veregen (kunecatechins) FDA Approval History

View comments

Hide
(web3)